Collectively, findings from both in vitro and in vivo provide compelling evidence for critical regulatory roles of Nox2 in proinflammatory cytokine-induced ROS generation and metabolic dysfunction culminating in the onset of islet dysfunction and diabetes. This evidence concerns the gene CYBB and diabetes mellitus.